Drug Research
Fatty Liver Disease Gets A Novel Drug Healing Contender
Karolinska Institute researchers have come up with a promising antibody medication candidate for the medication of non-alcoholic fatty liver disease.
There is presently no treatment for non-alcoholic fatty liver disease, which affects individuals with type 2 diabetes and can develop...
Clinical Trials
Clinical Trials Information System A Must In The EU Now
All initial clinical trial applications across the EU have to be submitted via the Clinical Trials Information System (CTIS) starting January 31, 2023.
As per the European Medicines Agency (EMA), CTIS now happens to be the single-entry point for regulators...
News
Mechanism For Lung Adenocarcinoma Established By Researchers
Researchers have identified the mechanism that is responsible for the formation of cancer-associated fibroblasts, which happen to be essential for lung adenocarcinoma.
Lung adenocarcinoma is the most frequent type of cancer of the lungs. It is related to cancer cells...
Drug Research
Singapore Witnesses A $50mn Funding In Research & Innovation
NUS Academic Medical Centre and SingHealth in Singapore have announced a gift of $50 million, which will be transformational, from the Lee Foundation that will aid in providing support for the advancement of research and innovation via programmes as...
Drug Research
Novel Research Says Actin A Key Source of Spreading Cancer
The University of Freiburg researchers have found out that the release of prometastatic factors is influenced by the skeleton of the cell, known as actin.
As per a research team that was led by Dr. Robert Grosse and Dr. Carsten...
Drug Research
Genomic Ties Announced By UK With Thailand On Health Issues
A new partnership with Thailand to share the expertise of genome sequencing, research collaboration, education and training opportunities, as well as genomics data handling will help UK patients.
A MoU has been inked between deputy Prime Minister of Thailand, Anutin...
News
Digital media and ROI in Pharma
There was a pin-drop silence in the conference room. A senior executive from a multinational pharma company had asked me a question; “Which digital platform do you think is the best?”
His US headquartered boss wanted him to prioritize digital...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read